|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Share-based compensation | |||||
| Deferred income tax expense (benefit) | |||||
| Extinguishment of debt | |||||
| Extinguishment of debt and bridge fees | |||||
| Net gain on divestitures | |||||
| Non-cash restructuring charges | |||||
| Net (income) loss from unconsolidated investees | |||||
| Operating lease asset impairments | |||||
| Adenza purchase accounting adjustment | |||||
| Other reconciling items included in net income | |||||
| Net change in operating assets and liabilities, excluding the effects of divestitures: | |||||
| Receivables, net | |||||
| Other assets | |||||
| Accounts payable and accrued expenses | |||||
| Section 31 fees payable to SEC | |||||
| Accrued personnel costs | |||||
| Deferred revenue | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of securities | |||||
| Proceeds from sales and redemptions of securities | |||||
| Proceeds from divestitures, net of cash divested | |||||
| Acquisition of businesses, net of cash and cash equivalents acquired | |||||
| Purchases of property and equipment | |||||
| Investments related to default funds and margin deposits, net | |||||
| Other investing activities | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Repayments of commercial paper, net | |||||
| Repayments of debt and credit commitment | |||||
| Payment of debt extinguishment cost and bridge fees | |||||
| Proceeds from issuances of debt, net of issuance costs | |||||
| Repurchases of common stock | |||||
| ASR agreement | |||||
| Total repurchases of common stock | |||||
| Dividends paid | |||||
| Proceeds received from employee stock activity and other issuances | |||||
| Total proceeds received from employee stock activity and other issuances | |||||
| Payments related to employee shares withheld for taxes | |||||
| Default funds and margin deposits | |||||
| Other financing activities | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents and restricted cash and cash equivalents | |||||
| Net decrease in cash and cash equivalents and restricted cash and cash equivalents | |||||
| Cash and cash equivalents, restricted cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents, restricted cash and cash equivalents at end of period | |||||
| Supplemental Disclosure Cash Flow Information | |||||
| Interest paid | |||||
| Income taxes paid, net of refunds | |||||
| Reconciliation of Cash, Cash Equivalents and Restricted Cash and Cash Equivalents | |||||
| Cash and cash equivalents | |||||
| Restricted cash and cash equivalents | |||||
| Restricted cash and cash equivalents (default funds and margin deposits) | |||||
Loading...